Unable to display view head.php file not found.
 
 

Underberg - Figure 12 - Mortality Reduction in Subjects With Homozygous FH Correlates with Advances in Lipid-Lowering Therapy

Finally, more recent data from Circulation at the end of 2011 confirm again that survival probability, based on both major adverse cardiovascular events (MACE, top panel) and death (bottom panel), increases in patients on lipid therapy.  Although this was another observational study, the results confirm again that lipid lowering therapy dramatically improves outcomes in patients with FH.
Underberg J Clin Lipidol. 2012;
Complete references for all slides

References

[31] Arterioscler Thromb Vasc Biol. 2010;30:2673-2677.

Unable to display view foot.php file not found.